NCT04401176View on ClinicalTrials.gov

Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 15, 2020

Primary Completion Date

June 1, 2023

Study Completion Date

June 1, 2023

Conditions

Interstitial CystitisBladder Pain Syndrome

Interventions

DRUG

Heparin & Alkalinized Lidocaine Bladder Instillation

Bladder instillation instilled via catheter and to dwell for minimum of 30 minutes prior to spontaneous void

DRUG

Onabotulinum Toxin A

Intradetrusor onabotulinumtoxinA injection (0.5mL x 20 sites)

Trial Locations (1)

20889

Walter Reed National Military Medical Center, Bethesda

All Listed Sponsors

lead

Walter Reed National Military Medical Center

FED

NCT04401176 - Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome | Biotech Hunter | Biotech Hunter